
Sign up to save your podcasts
Or


Send us a text
Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.
By SHARE Cancer Support5
5858 ratings
Send us a text
Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.

91,052 Listeners

78,330 Listeners

43,702 Listeners

38,781 Listeners

27,229 Listeners

9,581 Listeners

43 Listeners

12,721 Listeners

112,904 Listeners

56,561 Listeners

12,375 Listeners

5,774 Listeners

5,438 Listeners

16,088 Listeners

53 Listeners